The binding of oligopeptides of general structure Lys-X-Lys (where X is an aromatic residue) to several polynucleotides has been studied by fluorescence spectroscopy. Two types of complexes are formed, both involving electrostatic interactions between lysyl residues and phosphate groups as shown by the ionic strength and pH dependence of binding. The fluorescence quantum yield of the first complex is identical with that of the free peptide. The other complex involves a stacking of the nucleic acid bases with the aromatic amino acid whose fluorescence is quenched. Fluorescence data have been quantitatively analyzed according to a model involving these two types of complexes. Association constants and the size of binding sites have been determined. Stacking interactions are favored in single-stranded polynucleotides as compared to double-stranded ones. A short oligopeptide such as Lys-X-Lys is thus able to distinguish between single-stranded and double-stranded nucleic acids. Fluorescence results are compared to those obtained by proton magnetic resonance and circular dichroism.
Abstract— Low temperature luminescence studies have provided evidence for interactions between the disulfide group of cystamine and adenine bases in cystamine‐poly(A) complexes and in cystamine‐adenosine aggregates. A quenching of adenine phosphorescence by cystamine was observed. At room temperature complex formation between cystamine and poly(A) was followed by proton magnetic resonance, absorption spectrophotometry and fluorescence using competition with a fluorescent peptide to monitor the binding process. These base‐disulfide interactions could be involved in the photochemistry of protein‐nucleic acid complexes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.